Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
ORMP Oramed Pharmaceuticals Inc rises 053 percent following release of its 2025 fourth quarter earnings results FVN Future reports quarterly results with no revenue or earnings data available as acquisition search continues Archimedes 3 ARCI Stock Valuation Metrics Overview 010 20260418 Is Filana Therapeutics FLNA stock appealing for longterm investors Slight Rise 20260420 Aehr Test AEHR shares surge 888 after Q1 loss narrows beating earnings estimates by 30 Lixte LIXT Stock Valuation Perspective Lixte Posts 027 EPS Loss Zero Q4 Revenue No Estimates Salesforce Inc CRM Positioned as Key Beneficiary of TD Cowens Upbeat Generative AI Adoption Survey Findings Eldorado EGO Q1 2026 Beat Revenue NA EPS Exceeds by Significant Audemars Piguet and Swatch Launch Royal Pop Pocket Watches A HighLow Culture Clash DTE Energy Co Under Review Analyst Report Highlights Utility Sector Positioning Homes 4 Rent AMH Q1 2026 Earnings Beat Revenue NA EPS 035 Black Titan BTTC Stock Today Drops 391 Key Support at 117 20260517 ProCap PCAP Stalls at 1025 Consolidation Phase 20260519 US Natural Gas Futures Decline as Warmer Weather Forecasts Reduce Heating Demand PutinXi Talks Advance Stalled Power of Siberia 2 Gas Pipeline Amid Iran War Energy Market Turmoil SoFi Technologies Posts Strong Quarter but Softens Forward Guidance Sun Pharma Reports 26 Rise in Q4 Net Profit Driven by Strong Sales and Strategic Investments Alibaba BABA FQ4 2026 Cloud AI Revenue Acceleration Highlights Potential Value in AI Space London Stock Exchange Group Reports Income Growth Led by Tradeweb VZ Q1 2026 Earnings EPS Beats Estimates by 381 as Stock Eases Back on Mixed Signals ALDX Q1 2026 Earnings Narrower Loss Beats Estimates Pipeline Progress Highlights NBBK Q1 2026 Earnings Earnings Miss as EPS Falls 285 Below Estimates agilon health Q1 2026 Earnings Massive EPS Beat Drives Stock Surge ARL Q3 2024 Earnings Net Loss Deepens as Real Estate Portfolio Pressures Persist TRDA Q1 2026 Earnings SmallerThanExpected Loss Offers Cautious Optimism Amid PreRevenue Stage Piper Sandler PIPR Faces Headwinds Stock Slips 22 Amid Market Pressure Estrella Immunopharma Warrant ESLAW Surges 1885 to 010 Faces Key Resistance at 011 OKE Shows Stability Near 88 ONEOK Inc Holds Steady Amid Mixed Market Signals Lion Group Holding Ltd LGHL Surges 25 to Key Resistance Level Immunovant IMVT Edges Lower Amid Consolidation Support and Resistance Levels in Focus